The development of esophageal squamous cell carcinoma (ESCC) is a multifactorial process, and associations between genetic variants and ESCC have been identified in genome-wide association studies. The aim of this study was to evaluate the effects of single nucleotide polymorphisms (SNPs) of long intergenic non-coding RNAs (lincRNAs) on ESCC susceptibility in Chinese populations. We scoured exons of lincRNAs located in ESCC susceptibility loci for all probable functional SNPs. These 52 SNPs were opted for and genotyped in 1493 ESCC patients and 1553 cancer-free controls from eastern and southern Chinese populations, and their associations with the risk for ESCC were estimated using logistic regression. Functional relevance was further examined by biochemical assays. Significant differences were found between patients and controls in the genotype frequencies for the rs11752942A>G site in the lincRNA-uc003opf.1 exon. Compared with the rs11752942AA genotype, AG and GG genotypes had a significantly reduced risk of ESCC (adjusted odds ratio = 0.73; 95% confidence interval = 0.63-0.84). Biochemical analysis demonstrated that, when compared with the A allele, the rs11752942G allele could markedly attenuate the level of lincRNA-uc003opf.1 both in vivo and in vitro by binding micro-RNA-149*, thereby affecting cell proliferation and tumor growth. These findings indicated that functional polymorphism rs11752942A>G in lincRNAuc003opf.1 exon might be a genetic modifier for the development of ESCC.
Introduction
Esophageal squamous cell carcinoma (ESCC), ranked as the eighth most common malignancy (1), occurs with increased frequency in specific regions (2) . Relative risk estimates have been reported for a number of factors associated with ESCC, including smoking (3), alcohol consumption (4), certain occupation (5) and diet patterns (6) . Moreover, there are reports of genetic alterations in patients with esophageal cancer (7) , especially, the association between single nucleotide polymorphisms (SNPs) and risk of ESCC has been reported (4, 8) , and it is generally considered that genetic susceptibility, environmental factors and gene-environment interactions all contribute to the development of ESCC (4, 9) .
Because of recent advances in high-throughput technologies, such as next-generation sequencing and very high-density microarrays, it will be possible to identify large number of genetic variants associated with human diseases by genome-wide association studies (GWAS) (10) , such as SNPs, insertions and deletions (indels) and copy number variations. GWAS have identified several susceptibility loci related to ESCC (4, 9, (11) (12) (13) (14) (15) (16) (17) . By bioinformatics analysis on the basis of UCSC, Ensembl, Refseq and long non-coding RNAs (lncRNAs) databases (18) , we found several long intergenic non-coding RNAs (lincRNAs) close to these loci. In addition, it has been revealed that most of the human genome is transcribed, generating a large repertoire of lncRNAs that map to intronic and intergenic regions (19, 20) .
Although only a small fraction of these transcripts have been described at length, it is clear that lncRNAs may play regulatory and structural roles through diverse molecular mechanisms in important biological processes, such as genomic imprinting, chromosome inactivation, cell differentiation and development, cell proliferation, protein nuclear import, organization of nuclear domains and apoptosis (21) . Previous studies have also reported that altered lncRNAs expression levels may be involved in the development of different human tumors (22) (23) (24) , attracting increasing interest in their use as biomarkers for diagnosis and prognosis, as well as potential therapeutic targets (23, (25) (26) (27) (28) . LncRNA MALAT-1 shows increased expression in patients with metastatic non-small cell lung cancer and other numerous types of tumors (28) . Levels of HOTAIR lncRNA have been reported as correlating with primary breast cancer invasiveness and metastasis (27) . LncRNA PCA3 in patient urine samples could represent a more sensitive and specific diagnosis of prostate cancer than the prostate-specific antigen currently in use (25) . The presence and overexpression of lncRNA HULC have been detected in hepatocarcinoma patients (29) . However, the molecular mechanism underlying the function of lncRNA has not yet been elucidated.
On the basis of the above description, we hypothesized that functional SNPs in lincRNAs might have altered expression levels associated with the development of ESCC. To test this hypothesis, we investigated the association between various lincRNA genotypes and the risk for the development of ESCC in two Chinese populations.
Materials and methods

Study subjects
Subjects participating in this study were ethnically homogenous Han Chinese derived from eastern and southern Chinese populations. In eastern China, 748 patients and 771 cancer-free controls recruited from Suzhou city were analyzed as a discovery set in this study (30, 31) . In southern China, 745 patients and 782 controls recruited from Guangzhou city were used as a validation set (Supplementary Table 1 , available at Carcinogenesis Online). In the eastern Chinese population, patients were consecutively recruited from urban hospitals in Suzhou with a response rate of 89%, between 2001 and 2009. Meanwhile, controls were selected from a 3500 person nutritional survey conducted in Suzhou city, with a response rate of 90%. In the southern Chinese population, patients were recruited from the Tumor Hospital affiliated with Guangzhou Medical College over the same period, with a response rate of 91%. Controls were selected from a pool of 5000 individuals who participated in a community-based screening program for health checkup conducted in Guangdong Province over the recruitment period. Tumor staging and pathological type were evaluated according to the 2002 American Joint Committee on Cancer staging system. Patients or controls who recently (in the last 6 months) had blood transfusions were excluded. There was no age, sex and stage restriction for the cases. All healthy controls had no documented history of cancer and were frequency matched to the cancer patients on the basis of their age (±5) and sex. In the Suzhou center, the average age was 58 years (range, 23-83 years) for the patients and 59 years (range, 23-93 years) for the control subjects (P = 0.58); in the Guangzhou center, the average age was 59 years (range, 26-87 years) for the patients and 59 years (range, 24-86 years) for the control subjects (P = 0.61). Informed consent was LincRNA polymorphism and esophageal carcinoma obtained from each participant, and this study was approved by the Medical Ethics Committee of Soochow University and the Institutional Review Boards of Guangzhou Medical University.
SNP selection and genotyping
We searched for published literature regarding associations between variants identified in GWAS and risk of ESCC and these relevant literatures were made available in the PubMed database up to 2012. SNPs located in lincRNAs with allelic frequencies were screened on the basis of reported ESCC susceptibility loci (10q23, 20p13, 5q11, 6p21, 12q24, 21q22, 7p15.3, 4q23, 16q12.1, 17q21, 22q12, 3q27, 17p13, 18p11, 2q22 and 13q33) and human lncRNA database (18) , UCSC, Ensembl and Refseq databases using Haploview software 4.2 based on the 1000Genome data set and the Chinese Han Beijing population data in HapMap (HapMap Data Rel 27 Phase II + III, February 2009, on NCBI B36 assembly, dbSNP b126). Finally, 52 SNPs (minor allele frequency > 0.01 in 1000Genome data set or minor allele frequency > 0.01 in the Chinese Han Beijing population data in HapMap) located on exons in 15 lincRNAs were selected (Supplementary Figure 1 , available at Carcinogenesis Online). All subjects were genotyped for the 52 SNPs by allele-specific MALDI-TOF mass spectrometry (Sequenom, San Diego, CA) (32, 33) . Two hundred samples were randomly selected for direct sequencing to confirm the genotyping results from the mass spectrometric analysis and were found to be 100% concordant (Supplementary Figure 2 , available at Carcinogenesis Online).
In silico prediction of rs11752942 on lincRNA-uc003opf.1 folding structures It is well known that specific structure determines function and that structure changes are likely to influence functions. Here, a 129 bp polymorphism-flanking region was analyzed using RNAfold and SNPfold to predict the putative impact of rs11752942 on local folding structures of lincRNA-uc003opf. 1 . In addition, the changes in micro-RNA (miRNA) binding sites caused by rs11752942A to G of lincRNA-uc003opf.1 were predicted using a bioinformatics analysis software program (http://bioinfo.uni-plovdiv.bg/microinspector/).
Animals and cell culture
Female BALB/c nude mice that were 4-5 weeks of age were purchased from the Shanghai Laboratory Animal Center at the Chinese Academy of Sciences (Shanghai, China). The mice were allowed to acclimate to local conditions for at least 1 week and were maintained on a 12 h light-dark cycle with food and water ad libitum. All the experiments were carried out in accordance with the guidelines approved by the Laboratory Animal Center of Soochow University. The human ESCC cell lines (TE-1 and EC9706) were purchased from Cell Bank of Type Culture Collection of Chinese Academy of Sciences, Shanghai Institute of Cell Biology, and were passaged for fewer than 6 months. TE-1 and EC9706 cells were cultured in RPMI 1640 medium (Gibco BRL, Gaithersburg, MD) supplemented with 10% fetal bovine serum (Gibco BRL) and 1× antibiotics/antimycotics at 37°C in the presence of 5% CO 2 .
Subcellular fractionation
To determine the cellular localization of lincRNA-uc003opf.1, cytosolic and nuclear fractions were collected from TE-1 and EC9706 cells as per the manufacturer's instructions for the Nuclear/cytoplasmic Isolation Kit (Biovision).
Construction of reporter plasmids, transient transfections and luciferase assays
We predicted that genetic mutation rs11752942A>G of the lincRNAuc003opf.1 exon might bring about miRNA-149* binding sites, and thus, theoretically, change the expression level of lincRNA-uc003opf.1. The reporter vector psiCHECK-2 (Promega, Madison, WI) was prepared with a 155 bp lincRNA-uc003opf.1 exon region fragment flanking the G or A allele polymorphism. TE-1 and EC9706 cells were seeded at 1 × 10 5 cells per well in 24-multiwell plates (BD Biosciences, Bedford, MA). After 16 h, in each well, 800 ng of reporter plasmids were cotransfected with 0, 1 or 40 pmol of miRNA-149* miRNA mimics (Ambion, Austin, TX) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Each group had six replicates, and the experiment was repeated at least three times. Twentyfour hours after the transfection, the cells were collected using 100 μl passive buffer to detect Renilla luciferase activity with the Dual-Luciferase Reporter Assay System (Promega) in the TD-20/20 luminometer (Turner Biosystems, Sunnyvale, CA); firefly luciferase activities were also determined to normalize the activity of Renilla luciferase.
Quantitative real-time PCR analysis
To explore the effects of different genotypes for rs11752942A>G on lincRNAuc003opf.1 levels, the relative levels of lincRNA-uc003opf.1 were detected using the quantitative real-time PCR (qRT-PCR) analysis from 35 samples obtained from patients whose genotypic data were anonymous. Briefly, TRIzol reagent (Molecular Research Center) was used to extract total RNA from samples and an aliquot of total RNA (1 μg) was reverse transcribed into single-strand complementary DNA using the M-MLV First Strand Kit (Invitrogen). The relative levels of lincRNA-uc003opf.1 were detected using the ABI Prism 7000 sequence detection system (Applied Biosystems) with the SYBR-Green method and GAPDH as the internal control. The primers used for lincRNA-uc003opf.1 complementary DNA were 5′-ACTTGCACCTGGAATGCTGGG-3′ and 5′-GTGCGTTTGCTGCTTGGACC-3′. For GAPDH, the primers used were 5′-GAAGGTGAAGGTCGGAGTC-3′ and 5′-GAAGATGGT GATGGGATTTC-3′. The levels of lincRNA-uc003opf.1, U6 and GAPDH in the nucleus and cytoplasm of ESCC cell lines were examined using qRT-PCR. The relative levels of lincRNA-uc003opf.1 in collected TE-1 and EC9706 cells were also detected using qRT-PCR. The basal expression of miRNA-149* in TE-1 and EC9706 cells was determined using the All-in-One miRNA qRT-PCR Detection Kit (Fulengen, Guangzhou, China).
Actinomycin D assay TE-1 and EC9706 cells were seeded at 5 × 10 4 cells per well in 10 mm 24-multiwell plates. Sixteen hours later, the cells were transiently transfected using Lipofectamin 2000 (Invitrogen) and cotransfected with 1 or 40 pmol miRNA-149* miRNA mimics (Ambion) with or without 40 pmol miRNA-149* miRNA inhibitor, as indicated, for 24 h; the cells were then further exposed to actinomycin D (Sigma, St Louis, MO) for 1, 2 and 3 h. The cells were harvested and the stability of the lincRNA-uc003opf.1 messenger RNA (mRNA) was analyzed using qRT-PCR. Actinomycin D was used at 2 mg/l. 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
Cell cycle analysis
Following transient transfection with miRNA-149* miRNA mimics, with or without the inhibitor for 24 h, the TE-1 and EC9706 cells were collected and fixed with 70% ethanol overnight at 4°C. Subsequently, we labeled single-cell suspensions with 50 μg/ml propidium iodide (Sigma) and analyzed using flow cytometry. Using FlowJo Software (Treestar, Ashland, OR), 10 000 cells were evaluated and the percentage of cells in the G 2 phase was denoted by the 2N population phase.
Lentiviral production and transduction
A 103 bp precursor sequence of miRNA-149* with artificial XhoI and NotI enzyme restriction sites was synthesized by Genewiz Company (Suzhou, China) and then cloned into the lentiviral expression vector pLVX-IRES-neo (Clontech Laboratories, San Francisco, CA). The control lentivirus was producted using empty espression vector, which did not contain the precursor sequence of miRNA-149*. The resulting constructs (pLVX-IRES-neo-miRNA-149*) were verified by direct sequencing. Using a three-plasmid transient cotransfection method (Lenti-T HT packaging mix, Clontech), replication-defective VSV-G pseudotyped viral particles were packaged in human embryonic kidney cells LentiX 293T (Clontech Laboratories). Lentivirus was harvested and concentrated. For transduction, TE-1 and EC9706 cells were infected with the control lentivirus (empty vector containing only lentivirus without the miRNA-149* fragment) and miRNA-149* lentivirus. After 48 h of transduction, the cells were stably selected with G418 at 500 μg/ml (Gibco, Lyon, France), and the drug-resistant cell populations were used for subsequent studies.
Mouse model TE-1-empty vector, TE-1-miRNA-149*, EC9706-empty vector and EC9706-miRNA-149* cells were diluted to a concentration of 5 × 10 6 per milliliter in physiological saline, and 0.1 ml of the suspension was injected subcutaneously into the posterior flank of mice. Five nude mice were used for each group. When a tumor was palpable, tumor growth was measured every other day after subcutaneous injection of tumor cells on one or both sides of the back of syngeneic mice by measuring the two largest perpendicular diameters with calipers, and tumor volume was calculated according to the following formula:
(L, length; W, width).
Statistical analysis
The distribution of age and gender between the ESCC patients and healthy controls, as well as alleles and genotypes, was appraised using two-sided chi-square test. Associations between case-control status and each SNP were evaluated using the odds ratio (OR) and its corresponding 95% confidence ). The differences in luciferase reporter activity and lincRNAuc003opf.1 levels among the ESCC patients with different genotypes were analyzed using Kruskal-Wallis test and one-way analysis of variance. All analyses were performed in a two-sided fashion by using SAS (version 9.1; SAS Institute), and P < 0.05 was defined as statistically significant.
Results
Genotypes and risk of ESCC
The relation of all the 52 SNPs with ESCC was examined in eastern (748 cases and 771 controls) and southern (745 cases and 782 controls) Chinese populations. Genotyping results showed that only rs11752942 on lincRNA-uc003opf.1 at 6p21.2 was significantly associated with ESCC risk in both eastern and southern Chinese populations (Table I ). In the eastern Chinese population, the frequency of the rs11752942AG and GG genotypes was significantly higher in patients with ESCC (P value = 1.0 × 10 −4 ) compared with the healthy controls. The adjusted ORs of carrying the rs11752942AG and GG genotypes in Suzhou cancer patient groups were 0.78 (95% CI = 0.63-0.98) and 0.60 (95% CI = 0.42-0.84), respectively, compared with the rs11752942AA genotype. The association was confirmed in the southern population where the ORs of carrying the rs11752942AG and GG genotypes in cancer patients were 0.78 (95% CI = 0.63-0.96) and 0.52 (95% CI = 0.37-0.74), respectively, compared with the rs11752942AA genotype (P value = 4.2 × 10 −3 ) (Table II) . We further examined the risk of ESCC related to lincRNAuc003opf.1 genotype with stratification analysis among different subgroups of age, sex, smoking, alcohol intake, BMI, pathological type, stage and family history of ESCC. As indicated in Table III , the protective effect of rs11752942A>G on ESCC was more significant in alcohol non-drinking subgroups (P = 0.003).
Cellular characterization of lincRNA-uc003opf.1 To determine the cellular localization of lincRNA-uc003opf.1, we fractionated ESCC cell lines into nuclear and cytoplasmic fractions. We can thoroughly separate nucleus from cytoplasm, as indicated by the results showing that GAPDH mRNA was exclusively detected in the cytoplasmic fraction, whereas the transcriptional level of nucleusretained U6 was predominantly found in the nuclear fraction. For EC9706 cell line, qRT-PCR analysis revealed that (mean ± SD) 40.3 ± 17.3% lincRNA-uc003opf.1 was detected in the nuclear fraction, and 59.7 ± 17.3% resided in the cytoplasm fraction. We got the similar results in TE-1 cell line that 39.7 ± 9.5% and 60.3 ± 9.5% lincRNAuc003opf.1 were detected in the nuclear fraction and the cytoplasm fraction, respectively ( Figure 1A) .
According with in silico prediction, local folding structures of lincRNA-uc003opf.1 greatly changed with the rs11752942A>G alteration ( Figure 1B) , with the minimum free energy decreasing from −0.60 to −1.70 kcal/mol and the appearance of a miRNA-149* binding site. Moreover, we found that there was much lower basal expression of miRNA-149* in ESCC cells than U6 (mean ± SD, 0.021 ± 0.006 versus 1.010 ± 0.158; P < 0.001), and no significant difference between levels of miRNA-149* in TE-1 cells (0.022 ± 0.006) and in EC9706 cells (0.020 ± 0.006) was observed (P = 0.568) ( Figure 1C) .
Effects of rs11752942A>G on lincRNA-uc003opf.1 in ESCC cell lines by binding miRNA-149* Two luciferase reporter gene constructs were framed, spanning 155 bp of the lincRNA-uc003opf.1 exon region, with an A or G allele at rs11752942 polymorphic sites in psiCHECK-2 (Figure 2A) . These constructs were used to transiently transfect ESCC cell lines (i.e. TE-1 and EC9706 cells). As revealed in Figure 2B , compared with the construct containing the rs11752942A allele, the construct containing the rs11752942G allele significantly reduced luciferase activity in a miRNA-149* concentration-dependent manner in TE-1 cells (1 pmol miRNA-149*: 1.521 ± 0.151 versus 1.767 ± 0.082, P = 0.029; 40 pmol miRNA-149*: 1.288 ± 0.076 versus 1.757 ± 0.171, P = 0.002). When above experiments were repeated in EC9706 cells, we obtained similar results as shown in Figure 2C (1 pmol miRNA-149*: 2.177 ± 0.154 versus 2.574 ± 0.247, P = 0.034; 40 pmol miRNA-149*: 1.964 ± 0.200 versus 2.470 ± 0.360, P = 0.021). There was no significant differences in luciferase activity between the two recombinants with rs11752942G allele and with rs11752942A allele when psiCHECK-2-uc003opf.1-exon with 40 pmol miRNA-149* and its corresponding inhibitor were separately cotransfected into TE-1 (1.852 ± 0.146 versus 1.804 ± 0.090, P = 0.596) and EC9706 cells (2.713 ± 0.214 versus 2.638 ± 0.336, P = 0.719). These results suggested that miRNA-149* might bind tightly to lincRNA-uc003opf.1 exon containing the rs11752942G allele, negatively regulating the level of lincRNA-uc003opf.1.
Effects of rs11752942A>G genotypes on lincRNA-uc003opf.1 level The effects of rs11752942A>G SNP on lincRNA-uc003opf.1 mRNA levels were additionally assessed by qRT-PCR of lincRNA-uc003opf.1 in 35 esophageal tissue samples. As a result, subjects with the rs11752942AA genotype expressed significantly higher lincRNAuc003opf.1 levels (0.178 ± 0.009) against GAPDH than those with the rs11752942AG (0.090 ± 0.005) or rs11752942GG genotype (0.013 ± 0.0002; analysis of variance test: P < 0.001; linear regression test: P < 0.001, Figure 2D ). In addition, DNA sequencing showed that TE-1 cells carried GG genotype for rs11752942, whereas rs11752942AA genotype was found in EC9706 cells. We assessed by qRT-PCR of lincRNA-uc003opf.1 in both EC9706 and TE-1 cells and found that there was a statistically significant difference (0.0286 ± 0.002 versus 0.0232 ± 0.007, P = 0.003) between the levels of lincRNA-uc003opf.1 in EC9706 cells with rs11752942AA genotype and in TE-1 cells with rs11752942GG genotype (Supplementary Figure 3A, available at Carcinogenesis Online). To determine the expression of miRNA-149*of different individuals, which might affect lincRNA-uc003opf.1 levels, we also assessed the levels of miRNA-149* in these 35 esophageal tissue samples by qRT-PCR, and no statistically significant difference among samples with rs11752942AA (0.030 ± 0.009), AG (0.031 ± 0.009) and GG (0.039 ± 0.011) genotypes (P = 0.147) was found (Supplementary Figure 3B , available at Carcinogenesis Online).
Effects of rs11752942A>G genotypes on cells' proliferation by binding miRNA-149*
Based on the previous discovery, the presence of a G allele for rs11752942 might generate a miRNA-149* binding site on lincRNA-uc003opf.1. To evaluate the effects of rs11752942 on lincRNA-uc003opf.1 in the two cell lines, we transiently transfected miRNA-149* into TE-1 (rs11752942GG) and EC9706 (rs11752942AA) cells, respectively. As shown in Figure 3A , in rs11752942GG cells, after RNA synthesis was blocked with actinomycin D for 1 h, the level of lincRNA-uc003opf.1 was downregulated from 100 to 88 ± 2.1%, and the remaining level of lincRNA-uc003opf.1 using actinomycin D for 2 h in the presence of 1 pmol miRNA-149* was about 70 ± 1.5%. Also, the remaining level of lincRNA-uc003opf.1 using actinomycin D for 1 h in the presence of 40 pmol miRNA-149* was only 3 ± 1.9%. Therefore, the results showed that levels of lincRNA-uc003opf.1 were downregulated significantly in a miRNA-149* dosage-dependent manner and according to the time of exposure to actinomycin D (P = 0.022) in rs11752942GG cells. However, no significant change was found in rs11752942AA cells (P = 0.348). The results of the MTT assay ( Figure 3B ) showed a relative cell viability in ESCC cells with rs11752942GG genotype of ~60.917 ± 0.799% following transfection with miRNA-149* for 4 days, Figure 3C ). a Data were for the combined discovery and validation sets. b ORs were adjusted for age, sex, BMI, smoking, drinking and family history of ESCC as appropriate in a logistic regression model. c P value of the test for homogeneity between stratum-related ORs for linc-ucoo3opf.1 (rs11752942AG + GG versus AA genotypes). P < 0.05, the values of which were presented in bold, was defined as statistically significant.
LincRNA polymorphism and esophageal carcinoma
Effects of rs11752942A>G genotypes on tumor growth by binding miRNA-149* We evaluated the effects of rs11752942A>G genotypes on tumor growth in different animal models. All mice were injected with rs11752942GG (TE-1)-empty vector, rs11752942GG (TE-1)-miRNA-149*, rs11752942AA (EC9706)-empty vector or rs11752942AA (EC9706)-miRNA-149* cells at the same time (five mice per group). As shown in Figure 3D , tumor growth from rs11752942GG (TE-1)-miRNA-149* cell xenografts began 4 days later than that of tumors formed from rs11752942GG (TE-1)-empty vector cell xenografts, and the mean tumor volume after 4 weeks in the former group was ~870 ± 128 mm 3 , ~430 mm 3 smaller than the latter. In contrast, growth of tumors from rs11752942AA (EC9706)-miRNA-149* cell xenografts was not inhibited when compared with that of tumors formed from rs11752942AA (EC9706)-empty vector cell xenografts.
To investigate whether these findings have general validity, we used two additional models. rs11752942GG (TE-1) and rs11752942AA (EC9706) wild-type cells were subcutaneously injected into mice back, and tumor growth was comparable with that of tumors formed from rs11752942GG (TE-1)-empty vector and rs11752942AA (EC9706)-empty vector cell xenografts.
Discussion
In the present study, we investigated the effects of 52 polymorphisms present in lincRNA exons on the risk of developing ESCC, and we found a significant association between individuals carrying at least one G allele (AG, GG) of the rs11752942A>G polymorphism in the lincRNA-uc003opf.1 exon and a significantly lower risk of ESCC than in individuals with homozygous A alleles. In the stratification analysis, it appeared that the protective effect of this polymorphism was more pronounced in non-drinkers, namely, the high risk of ESCC was more pronounced in alcohol drinking subjects, which is in line with the conception that ESCC is a complex disease that its etiology is related to environmental exposures, genetic loci and gene-environment interactions. It had been reported that alcohol drinking was one of major risk factors for ESCC (4, 9, 34) , and our finding also indicated a gene-environment interaction between alcohol use and genetic variation for developing ESCC. Moreover, when we performed additional biochemical analysis (luciferase assays, qRT-PCR, actinomycin D assay and MTT assay) and the construction of mouse model, we obtained consistent results that the rs11752942G allele can markedly attenuate the level of lincRNA-uc003opf.1 by binding miRNA-149*, thereby affecting cell proliferation and tumor growth. This represents the first report showing that the rs11752942A>G polymorphism may serve as a predictive marker for the risk of ESCC.
Environmental factors contributing to the development of ESCC have been extensively studied. However, there are also a number of molecular epidemiology studies pertaining to its genetic factors, especially SNPs. These reports on the SNPs functionally related to ESCC progress mainly concentrated on the tumor-suppressor gene p53 (35) (36) (37) (38) , given its importance in cellular growth control once DNA has been subjected to damage or mutation. Additionally, GWAS had been conducted to identify genetic susceptibility loci for ESCC (9, (11) (12) (13) . Numerous lincRNAs located nearby to these loci. Although it had been reported that lincRNAs played crucial roles in regulation and structure, the molecular mechanisms underlying the function of lncRNAs has not yet been clarified.
Cabianca et al. (39) described a novel lncRNA DBE-T that plays an important role in human disease through its involvement in gene regulation. In that study, lncRNA was posited as a master regulator of retrogene, which has conserved its open reading frame intact during mammalian evolution and has a role in the etiology of an important human disorder, and lncRNA was additionally found to regulate changes in chromatin conformation from a heterochromatic/close state to a more euchromatic/open condition. Rinn et al. (40) found that another lncRNA, HOTAIR, could recruit the PRC2 complex to silence 40 kb of the HOXD locus. It has been widely reported that the PcG protein complex, a major player in cell-specific recruitment of PRC2 and regulator of PcG target genes, interacts with lncRNAs. LncRNAs may interact with their specific target gene through a linear base pairing with the target sequences. Base-to-base complementarity seems the most effectual method of directing proteins against regulatory DNA elements. Besides, tertiary structure of lncRNAs may be key in allowing them to adjust protein production or DNA expression (41) . Mattick (21) summarized that lncRNAs might play regulatory and structural roles through diverse molecular mechanisms in critical biological processes, such as in genomic imprinting, chromosome inactivation, cell differentiation and development, cell proliferation, protein nuclear import, organization of nuclear domains and apoptosis. Additionally, interactions between lncRNA and miRNA in the cytoplasm have been reported (42) , and miRNA may regulate lncRNAs in a non-canonical manner in nucleus (43) .
Our findings showed that ~60% lincRNA-uc003opf.1 was detected in the cytoplasm fraction, so there is a likelihood of regulatory mechanisms existing outside the nucleus, and the results of our research also provided strong evidence for this hypothesis. Our phenotype experiment also proved that there were significant differences in the expression of lincRNA-uc003opf.1 in different rs11752942 genotypes, and our studies, both in vitro and in vivo, had suggested that the change of rs11752942A to G might directly affect tumor development. Our cell cycle analysis showed that lincRNA-uc003opf.1 with rs11752942GG genotype could contribute to G 2 phase arrest, so that cells could not smoothly pass through G 2 /M to split, and this suggests that lincRNAuc003opf.1 plays an important role in cell cycle and thus interferes with cell proliferation and tumor growth. Although the level of miRNA-149* is very low, it has known that miRNA-149* play important roles in multiple biological and metabolic processes in human cancer cells (44) , melanoma (45) and chondrocytes (46) . In addition, miRNA expression was related to head and neck cancer associated with alcohol consumption (47) , suggesting that alcohol consumption might affect miRNA and lincRNA, thereby affecting tumorigenesis, which was consistent with our results.
The major strength of our study is the relatively large population size, allowing us to conduct analyses in a discovery set and validation set, limiting the confounding effect of population heterogeneity. The significant rs11752942A>G SNP remained significant following adjustment for multiple comparison, validated in the validation set and consistent with our functional findings. Moreover, we have achieved a study power of over 90% (two-sided test, α = 0.05) in detecting an OR of 0.73 for the rs11752942AG + GG genotypes (occurring at a frequency of 61.0% among the controls) when compared with the rs11752942AA genotype. Nevertheless, because ESCC is a complex disease, larger scale studies preferably accounting for gene-gene and gene-environment interactions in population-based case-control studies with enhanced statistical power and different genotyping panels, as well as well-designed mechanistic studies, are warranted to confirm the real contribution of the polymorphism to ESCC susceptibility in Chinese populations or to investigate the association between this polymorphism and different tumors in different ethnicities.
Our findings suggest that miRNA-149* might bind tightly to lincRNA-uc003opf.1 in the presence of rs11752942G allele, and downregulate the level of lincRNA-uc003opf.1, influencing cell proliferation ability and so reducing the occurrence of ESCC.
In conclusion, our study demonstrated that lincRNA-uc003opf.1 rs11752942GG and rs11752942AG genotypes may reduce the risk of ESCC in eastern and southern Chinese populations by binding miRNA-149*. To the best of our knowledge, studies of functional polymorphisms in lincRNA exons have so far been infrequent, their associations with ESCC have not been investigated and our study was the first to demonstrate a significant association between lincRNAuc003opf.1 rs11752942A>G polymorphisms and ESCC risk. The results of our study further prompt assumptions that miRNA may regulate lincRNA expression by the combination of lincRNA exon, thereby affecting tumor susceptibility.
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